131 related articles for article (PubMed ID: 16801244)
1. Colon-specific delivery of mesalazine chitosan microspheres.
Varshosaz J; Jaffarian Dehkordi A; Golafshan S
J Microencapsul; 2006 May; 23(3):329-39. PubMed ID: 16801244
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of zinc and 5-aminosalicylic acid from alginate/N-succinyl-chitosan blend microspheres for synergistic therapy of colitis.
Duan H; Lü S; Qin H; Gao C; Bai X; Wei Y; Wu X; Liu M; Zhang X; Liu Z
Int J Pharm; 2017 Jan; 516(1-2):214-224. PubMed ID: 27851980
[TBL] [Abstract][Full Text] [Related]
4. Colon-specific delivery of 5-aminosalicylic acid from chitosan-Ca-alginate microparticles.
Mladenovska K; Raicki RS; Janevik EI; Ristoski T; Pavlova MJ; Kavrakovski Z; Dodov MG; Goracinova K
Int J Pharm; 2007 Sep; 342(1-2):124-36. PubMed ID: 17590293
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.
Umadevi SK; Thiruganesh R; Suresh S; Reddy KB
Biopharm Drug Dispos; 2010 Oct; 31(7):407-27. PubMed ID: 20848388
[TBL] [Abstract][Full Text] [Related]
6. Validation of a pharmacokinetic model of colon-specific drug delivery and the therapeutic effects of chitosan capsules containing 5-aminosalicylic acid on 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats.
Tozaki H; Fujita T; Odoriba T; Terabe A; Okabe S; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Oct; 51(10):1107-12. PubMed ID: 10579681
[TBL] [Abstract][Full Text] [Related]
7. Chitosan capsules for colon-specific drug delivery: enhanced localization of 5-aminosalicylic acid in the large intestine accelerates healing of TNBS-induced colitis in rats.
Tozaki H; Odoriba T; Okada N; Fujita T; Terabe A; Suzuki T; Okabe S; Muranishi S; Yamamoto A
J Control Release; 2002 Jul; 82(1):51-61. PubMed ID: 12106976
[TBL] [Abstract][Full Text] [Related]
8. Colon specific chitosan microspheres for chronotherapy of chronic stable angina.
Jose S; Prema MT; Chacko AJ; Thomas AC; Souto EB
Colloids Surf B Biointerfaces; 2011 Apr; 83(2):277-83. PubMed ID: 21194900
[TBL] [Abstract][Full Text] [Related]
9. Chitosan microspheres of aceclofenac: in vitro and in vivo evaluation.
Nagda C; Chotai N; Patel S; Nagda D; Patel U; Soni T
Pharm Dev Technol; 2010; 15(5):442-51. PubMed ID: 20735299
[TBL] [Abstract][Full Text] [Related]
10. Chitosan as a pore former in coated beads for colon specific drug delivery of 5-ASA.
Omwancha WS; Mallipeddi R; Valle BL; Neau SH
Int J Pharm; 2013 Jan; 441(1-2):343-51. PubMed ID: 23200955
[TBL] [Abstract][Full Text] [Related]
11. N-Succinyl-chitosan systems for 5-aminosalicylic acid colon delivery: in vivo study with TNBS-induced colitis model in rats.
Mura C; Nácher A; Merino V; Merino-Sanjuan M; Carda C; Ruiz A; Manconi M; Loy G; Fadda AM; Diez-Sales O
Int J Pharm; 2011 Sep; 416(1):145-54. PubMed ID: 21723929
[TBL] [Abstract][Full Text] [Related]
12. Design and development of multiparticulate system for targeted drug delivery to colon.
Chourasia MK; Jain SK
Drug Deliv; 2004; 11(3):201-7. PubMed ID: 15204639
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro evaluation of chitosan matrices for colonic controlled drug delivery.
Zambito Y; Di Colo G
J Pharm Pharm Sci; 2003; 6(2):274-81. PubMed ID: 12935439
[TBL] [Abstract][Full Text] [Related]
14. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.
Bautzová T; Rabišková M; Béduneau A; Pellequer Y; Lamprecht A
Eur J Pharm Biopharm; 2012 Jun; 81(2):379-85. PubMed ID: 22386911
[TBL] [Abstract][Full Text] [Related]
15. Bumadizone calcium dihydrate microspheres compressed tablets for colon targeting: formulation, optimization and in vivo evaluation in rabbits.
Nour SA; Abdelmalak NS; Naguib MJ
Drug Deliv; 2015 May; 22(3):286-97. PubMed ID: 24601826
[TBL] [Abstract][Full Text] [Related]
16. Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery.
Rai G; Jain SK; Agrawal S; Bhadra S; Pancholi SS; Agrawal GP
Pharmazie; 2005 Feb; 60(2):131-4. PubMed ID: 15739902
[TBL] [Abstract][Full Text] [Related]
17. Mesalazine-probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis.
Vishwakarma N; Ganeshpurkar A; Pandey V; Dubey N; Bansal D
Drug Deliv; 2015 Jan; 22(1):94-9. PubMed ID: 24491122
[TBL] [Abstract][Full Text] [Related]
18. In vitro degradation and drug-release properties of water-soluble chitosan cross-linked oxidized sodium alginate core-shell microgels.
Chen C; Liu M; Lii S; Gao C; Chen J
J Biomater Sci Polym Ed; 2012; 23(16):2007-24. PubMed ID: 21967992
[TBL] [Abstract][Full Text] [Related]
19. Chitosan/cellulose acetate microspheres preparation and ranitidine release in vitro.
Zhou HY; Chen XG; Liu CS; Meng XH; Yu LJ; Liu XY; Liu N
Pharm Dev Technol; 2005; 10(2):219-25. PubMed ID: 15926670
[TBL] [Abstract][Full Text] [Related]
20. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
Sareen R; Jain N; Rajkumari A; Dhar KL
Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
